Open Journal of Respiratory Diseases
Vol.3 No.2(2013), Paper ID 31404, 8
pages
DOI:10.4236/ojrd.2013.32006
Differential Mechanisms of the Effect of Peroxisome Proliferator-Activated Receptor Gamma Agonists on Bleomycin-Induced Lung Fibrosis
Keisuke Miyamoto, Sadatomo Tasaka, Yasushi Nakano, Hiromi Shinoda, Hirofumi Kamata, Wakako Yamasawa, Makoto Ishii, Naoki Hasegawa, Tomoko Betsuyaku
Division of Pulmonary Medicine, Keio University School of Medicine, Tokyo, Japan
Division of Pulmonary Medicine, Keio University School of Medicine, Tokyo, Japan
Division of Pulmonary Medicine, Keio University School of Medicine, Tokyo, Japan
Division of Pulmonary Medicine, Keio University School of Medicine, Tokyo, Japan
Division of Pulmonary Medicine, Keio University School of Medicine, Tokyo, Japan
Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan
Division of Pulmonary Medicine, Keio University School of Medicine, Tokyo, Japan
Center for Infectious Diseases and Infection Control, Keio University School of Medicine, Tokyo, Japan
Division of Pulmonary Medicine, Keio University School of Medicine, Tokyo, Japan
Copyright © 2013 Keisuke Miyamoto, Sadatomo Tasaka, Yasushi Nakano, Hiromi Shinoda, Hirofumi Kamata, Wakako Yamasawa, Makoto Ishii, Naoki Hasegawa, Tomoko Betsuyaku et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Miyamoto, K. , Tasaka, S. , Nakano, Y. , Shinoda, H. , Kamata, H. , Yamasawa, W. , Ishii, M. , Hasegawa, N. and Betsuyaku, T. (2013) Differential Mechanisms of the Effect of Peroxisome Proliferator-Activated Receptor Gamma Agonists on Bleomycin-Induced Lung Fibrosis.
Open Journal of Respiratory Diseases,
3, 31-38. doi:
10.4236/ojrd.2013.32006.